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Shape memory polymer foam hemostats are a promising option for 
future hemorrhage control in battlefield wounds. To enable their use as 
hemostatic devices they must be optimized in terms of formulation and 
architecture and characterized in terms of safety and efficacy. As a device 
advances through the stages of development, pre-clinical testing is 
required in animals. In order to help mitigate the excess use of animals as 
well as decrease the costs of pre-clinical research, relevant in vitro models 
need to be created and used for device optimization. In the work conducted 
here, two in vitro models were created; a simplified gunshot wound model 
and a grade V liver injury model were constructed and used for the testing 
of a variety of shape memory polymer foam hemostat geometries. The 
primary outcomes included how foam geometry affected wall pressures 
and hemorrhaging of the simulated blood. This work assisted in narrowing 
down hemostat design options based on the inflicted wound. After testing, 
the 8 different foam hemostat geometries pros and cons were elucidated, 
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1.1 Clinical Need: Uncontrolled Hemorrhage 
Each year soldiers enter the battlefield with hopes of returning home to their families. 
Unfortunately, approximately 20% of combat casualties are killed in action (KIA), better 
known as killed before reaching treatment [2]. Uncontrolled hemorrhage is the leading 
cause of preventable death on the battlefield with 50% of the 20% of KIA soldiers dying 
from hemorrhaging [2]. Hemorrhage is loss of blood from a damaged blood vessel [4]. It 
can lead to a fluctuation in vital signs and an altered mental status as it progresses [4]. If 
hemorrhaging is not stopped, a person can possibly bleed to death in approximately five 
minutes [3]. If a person were able to recognize bleeding and apply more rapid and 
effective hemorrhage controlling agent, up to 16% of deaths on the battlefield would have 
preventable [5] Overall, hemorrhage claims ~1.5 million deaths per year [5], 30-50% [6] 
of which occur outside of the hospital.  
 
1.2  Current Hemostat Solutions: Benefits and Drawbacks 
Current hemorrhage controlling agents, or hemostats, include gauze, gauze with the 
assistance of a tourniquet, and a newer option, XStat®. Gauze has been in use since 
the 1890s [9]. There are two main types of medical gauze: woven and non-woven, in 
which they can be both sterile and non-sterile [10]. Woven gauze uses a loose open 
wave which helps fluid pass through the gauze and be absorbed by a more absorbable 
dressings (i.e. gauze pad or sponges). Non-woven gauze is created from fibers that 
appear to be woven but instead it is just more condense helping this type of dressing 




polyester or rayon, [10] which makes it one of the more comfortable wound dressings. 
Gauze has the capability of forming to any area, making it very useful for any traumatic 
wound injury. The downfalls of gauze, used alone, is that it is not as effective as other 
methods. It causes re-bleeds after removal, often places high pressure on the 
surrounding wall tissue especially when inserted into the wound and can be disruptive 
to wound healing since it dries and eventually can cause tissue damage when it is 
removed [11]. Tourniquets were first introduced in the battlefield in 1674 [12]. A solider 
wrapped a tight band below or above the site of the wound with the hopes of reducing 
pain and minimizing hemorrhaging by reducing blood flow to the wound [12]. 
Tourniquets used in conjunction gauze helps maximize the efficiency of gauze. The less 
blood that is flowing, the more the gauze can serve as a hemorrhage controlling 
hemostat at a rate of up to 7% [13]. Although tourniquets help with pain and blood 
control, they are intended to stop blood flow completely [13]. The tightness of the 
tourniquet is dependent upon the size of the limb. The tightness, appropriate 
application, and tourniquet type used (strap vs. pneumatic) determine the amount of 
time the tourniquet can be used. In the result that any are inappropriately applied, 
tourniquet use has a time sensitivity that can result in nerve damage [13], or in extreme 
cases, limb amputation.   X-Stat® is a battlefield [8] hemostatic device built for wounds 
in the groin or axilla and narrow entrance extremity wounds that are unable to have 
tourniquets applied [7]. It consists of 3 sterile syringe applicators filled with ~92 pieces of 
cellulose expandable sponges with an absorbent animal-derived coating [8]. One 
application of sponges can absorb approximately 300 ml of blood totaling a maximum 




only be used for up to four hours until surgical care can be given. [7] Within the four 
hours, all cellulose expandable sponges must be removed from the patient. They have 
been developing sponges that are detectable via X-ray [8] to help assist surgeons in 
removal, but that can lead to an increase in removal time and cost. Current methods 
have benefits of forming to any area, helping to reduce blood flow to the wound, and 
easy application. Cons of the current methods include limited effectivity and time 
sensitivity. With these current downfalls, there is a clinical need for a hemostat that can 
be effectively applied/removed, is biocompatible, causes rapid blood clotting to stop 
bleeding, and does not have a time sensitive removal window. 
 
1.3 Shape Memory Polymer Foams  
Shape memory polymers (SMPs) are smart materials that can maintain any type of 
shape with the assistance of an external stimuli (i.e. temperature). They can 
“remember” a primary and secondary shape in which the key to their “memory” is shape 
recovery. See Figure 1 for an example showing a cycle of heating, deforming/molding, 
cooling and unloading [14]. The initial cycle creates the secondary shape. In order to 










SMP foams show great potential in hemostatic applications due to their high 
biocompatibility, high porosity, large surface area, and unique shape retention 
properties [15]. These foams have a highly porous shape that can compressed to a 
smaller volume in order to be inserted into any desired wound type. To fabricate SMP 
hemostats, foams are synthesized by mixing isocyanates and hydroxyls in traditional 
gas blowing processes. To prepare SMP foam hemostatic dressings, foams (1-2 liters) 
are cut into smaller sections, heated to their glass transition temperature, 45 to 70ºC in 
dry conditions [15], molded by compressing axially, and lastly cooled to lock in its 
secondary shape until it is ready to be applied to the bleeding wound. To tune the SMP 
glass transition temperature, the crosslink density of the network can be altered by 
varying ratios and end groups on isocyanate and hydroxyl monomers [15]. When the 
SMP is introduced to water, it causes plasticization, and the glass transition is reduced 
to below body temperature, based on network hydrophilicity and hydrogen bond 
disruption [16]. With the capability of tuning the glass transition temperature of a shape 
memory polymer foam hemostat, it permits the application of compressed foam(s) to 
deep and irregularly shaped wounds. Since wounds are at least the temperature for 
transition, the shape memory foam hemostats can expand back to their original shape 










The characteristics of the foams that we are looking for is average pore size of ~1000 
µm, a dry glass transition temperature > 50ºC, and a wet glass transition <37ºC. 
SMP foams have been tested in in vivo aneurysms and peripheral vasculature 
that resulted in demonstrated biocompatibility [32] and rapid clotting [17] [18]. Porcine 
models were used to analyze the biocompatibility and thrombus formation 
characteristics of SMP foams over a 90-day period via histological evaluation [17] [32]. 
The polyurethane SMP foams demonstrated that they can apply minimal pressure to the 
walls of the wound, be highly biocompatible, and aid in the clotting in of blood. In the 
swine aneurysm model, biocompatibility was tested by analyzing the neointima 
formation across the aneurysm neck which isolated the aneurysm for the parent vessel 
without the compromise of the lumen. Biocompatibility was also shown by observing the 
inflammatory response in comparison to other suture materials (i.e. silk and 
polypropylene) [32]. The inflammatory response was minimal and that motivated the 
declaration of biocompatible polyurethane SMP foams. Thrombogenesis was evident 
through analyzing the endothelization and topography of the parent artery interface. As 
the days progressed from 0-90, the red blood cells followed the steps of 
thrombogenesis (blood cells forming along a parallel direction) and ultimately 
completely covered the aneurysms with endothelial cells [32]. In vivo polyurethane SMP 
foam studies produced data showing the combination of thrombogenic surface 
chemistry and high surface area-to-volume ratio results in rapid blood clotting within the 





1.4 In Vitro Modeling 
 The SMP foam shows promise for addressing the current clinical needs but 
requires pre-clinical testing to demonstrate safety and efficacy. When creating a new 
medical device, it must go through pre-clinical testing processes set forth by the Food 
and Drug Administration (FDA) in order to be accepted into the market. In pre-clinical 
trials, in vivo studies are carried out on animals to predict how a device will perform in a 
human. It tests the safety and efficacy [24] of a device in order to declare that it is safe 
to use in humans. Approximately 26 million animals are used every year in the United 
States for scientific commercial testing [25]. Although animal testing can be very 
beneficial to the testing and regulation of a medical device, it has both benefits and 
limitations. Some benefits include real life characterization, testing is closer to the 
human body, demonstration of safety, a testing option when it is unethical to use human 
subjects, and animal life cycles are shorter enabling more rapid characterization of 
healing processes [25]. Some limitations include cost, loss of animal life, and 
differences between animals and humans [25] [26]. Thus, many devices and drugs that 
work in animals are not necessarily safe and effective in humans. In order to help 
mitigate the excess of animal testing, the creation and use of in vitro models is 
suggested [27]. 
 
1.4.1 Gun Shot Wound Model (Cylindrical Model) 
A cylindrical in vitro model was created to simulate a gunshot wound based on the in 
vitro model experiment conducted by Kragh [33]. With the direction of literature, a mock 




cavity, molded in polydimethylsiloxane (PDMS), to measure the pressures on the 
bottom and side of the model. The fluid would come into the bottom of the model at a 
pressure of 100 mmHg based on the average blood pressure of humans. The liquid was 
gravity fed into the wound, and a 22% glycerol solution was used to simulate blood [19]. 
This model allowed for the packing of the hemostats as well as quantitative 
observations of fluid loss and pressures of the hemostats. 
 
1.4.2 In Vitro Grade V Liver Wound Model 
To provide more clinically relevant measurements, an in vitro grade V liver injury 
model was subsequently built and used for testing. A grade V liver injury model was 
selected since the liver is the most commonly injured abdominal organ that causes 
hemorrhagic death [28] [29]. The gunshot wound model was molded in PDMS, which has 
very different material properties than a liver. PDMS has an elastic modulus range of 0.57 
MPa to 3.7 MPa [36] which is two orders of magnitude stiffer than human liver’s elastic 
modulus range of 560 Pa to 720 Pa [37]. Using a new material with a modulus closer to 
the liver, ballistic gel was selected since it had an elastic modulus range of 121 kPa to 
129 kPa [38]. The wound injury is characterized by the amount of lethal parenchymal 
damages along with major vascular lacerations. For an injury to be categorized as grade 
V, there must be at least two major blood vessels that have been cut, see Figure 3 for 
reference [30] [31]. The fluid flow rate is used to simulate this study. In literature, a 35-45 
kg pig has a liver size of ~1000g [34]. Since the constructed liver mold is smaller than 
that, using a 1:1 liver mass to fluid rate ratio [35], the flow rate could be calculated. In this 




and the pressure on the wound walls after application of SMP foams in comparison with 
gauze and XStat® controls, similarly to in vivo testing in a gunshot wound model. The 
grade V liver injury model simulates porcine studies that are part of the pre-clinical trials 












Figure 3. Liver showing the two lacerations of major blood vessels in order to 
classify a wound as grade V [photo by Henry Beaman, MBM LAB]. 
 
 
1.5 Research Overview 
In this study, I looked at how SMP foam hemostats perform in different in vitro 
models that simulate real life battlefield wounds and animal models to maximize 




literature that measure both side and bottom pressures, flow rate, fluid loss, and 
pressure on the walls.  
1.5.1 Varying Foam Geometries 
Shape memory polymers have the capability of being any shape or size. For wound 
packing hemostats, responders have the decision to use a standardized one size non-
woven gauze roll or small pieces of cellulose X-stat® pieces. In a gauze vs X-Stat® 
study, the different geometries did not significantly alter bleeding rates and 
hemorrhaging, but the X-Stat® was favored for hemorrhage control [19]. By having 
different hemostatic geometries, it is expected that there will be changes in how packing 
will occur, the changes in wall pressure, and changes in how the hemorrhage is 
controlled. In order to increase hemorrhage control, wound packing should be 
maximized [20] [21] by standardizing application methods and reducing material rigidity 
while packing.  
 





The SMP foams in these studies were fabricated in analogous geometries to the gauze 
roll and X-Stat® (Figure 4). The single cylinders form a SMP hemostat in the size of a 
gauze roll while the multiple cylinders are like the smaller pieces of X-stat®. Using 
different geometries of one material helps improve understanding of wound packing and 
hemorrhage control in terms of wall pressures and fluid collection. An added foam 
geometry is shredded foam that serves as a SMP that can expand freely beyond the 



























2.1 SMP Control Foam Synthesis 
 The control polyurethane foams were synthesized using the procedures 
described by Singhal et.al.1 This process begins with an isocyanate (NCO) pre-polymer 
mix that contains hexamethylene diisocyanate (HDI)  triethanolamine (TEA) and 
N,N,N’,N’‐tetrakis(2‐hydroxypropyl) ethylenediamine (HPED). The NCO pre- polymer 
mix is prepared inside a glovebox and allowed to react for 48 hours at 50 ºC. After 48 
hours, remove the (NCO) pre-polymer mixture and add surfactant. Allow the (NCO) pre-
mix to cool while preparing the OH mixture/ The OH mixture is then prepared with 
(catalysts, TEA, HPED and deionized water (DI)). Once the OH mix is prepared and 
speed mixed using a high-speed mixer (FlackTek, Inc., Landrum, SC), The NCO and 
OH mixtures are combined and mixed using the high-speed mixture then it is poured 
into a 2 L beaker to allow for foaming. The foam is then placed to cured in a laboratory 
oven at 50 ºC for 5 to 10 minutes to ensure completion of the reaction then it is placed 
in the fume hood overnight. 
 
2.2 Foam Characterization  
2.2.1 Differential Scanning Calorimetry (DSC) Glass Transition Temperature 
The glass transition temperature (Tg) was measured using a Q‐200 DSC (TA 
Instruments, Inc., New Castle, DE).  The foams Tg was observed under both wet and 
dry conditions. To measure dry Tg, foam samples were cut into pieces ranging from (3- 




temperature to 0 °C at 10 °C min-1 and hold isothermal for 2 minutes, 2) Increased 
temperature to 80 °C at 10 °C min−1 and hold isothermal for 2 minutes, 3) Decreased 
temperature to 0 °C at 10 °C min-1 and hold isothermal for 2 minutes, and 4) Increased 
temperature to 80 °C at 10 °C min−1 and hold isothermal for 2 minutes. This created 4 
cycles total, where dry Tg was then determined observing the second heating cycle. 
 
Before conducting wet Tg measurement, foam samples (3-5 mg), were placed 
into a glass vial containing DI water. The vials were placed into the laboratory oven at 
50 ºC for 15 minutes to fully plasticize. The samples were then removed from vials and 
patted dry using Kim wipes (Kimberly-Clark Worldwide, Inc.). The samples were placed 
into aluminum pans and covered with hermetic lids. The lids were then vented by 
inserting a small hole using a syringe needle. Using the Q-200 DSC, the same cycle 
program as dry Tg was utilized and the data was observed in the same heating cycle. 
 
2.2.2 Scanning Electron Microscopy (SEM) 
Foam pores were imaged using Joel NeoScope JCM‐5000 Scanning Electron 
Microscope (SEM). Samples (1 cm3) were cut and gold sputter coated for 45 seconds. 
Pore size was analyzed by a line drawn between the two farthest opposing pore walls 
using ImageJ. 
 
2.2.3 Shape Memory Behavior: Volume Recovery Expansion Study 
A water bath set to 37 ºC was prepared. Radially compressed foam miniature 




calipers. Nickel titanium wire was threaded through the center of the sample and 
attached to the base plate of the water bath apparatus. The base plate was placed into 
the water bath and images were taken every 5 seconds for 5 minutes via go pro. The 
foam sample’s diameter was re-measured after the 5-minute period using digital 
calipers. The images were analyzed using ImageJ where the foam diameter was 
measured for each individual image and scaled based on the initial and final measured 
diameters. 
 
2.3 Foam Geometry Preparation 
Foam samples were in the form of hot wire cut cylinders, hole punched cylinders 
and powder. The miniature cylinders (1.5 cm tall) were prepared using a wire cutter and 
a 1.5 cm diameter punch. The 100% cylinders (7 cm tall) were prepared using a wire 
cutter and a 3 cm diameter biscuit cutter punch. The 150% cylinders (7 cm tall) were 
prepared using a wire cutter and a 3.6 cm diameter biscuit cutter punch. Both 100% and 
150% cylinders used the biscuit cutters as indentations to mark the diameter in which 
the wire cutter would cut along the vertical axis. For the powder, leftover punched 1.5cm 
cylindrical disks were used. The volume of one 1.5cm x 1.5cm punch was measured 
and the volume of the punched cylindrical disks was calculated finding the mass of the 
matching disk and calculating volume via the density formula (density=mass/volume). 
Cylinders and the cylindrical punched disks were cleaned using a 10X volume wash of 
70% ethanol and 20X volume wash of deionized water. Each wash was done twice 
while on a shaker table for 5 minutes set at 100 rpm. Samples were then dried via 




minutes and then placed into a radial crimper to prepare radially compressed samples. 
Foams remained in the crimper for 2 minutes at room temperature. Powders were made 
from cylindrical punched disks by blending in a standard kitchen ninja blender. 
 
2.4 In Vitro Model Testing 
2.4.1 22% Glycerol Formulation 
22% glycerol mixture was created by measuring the volume of a glass container and 
calculating what 22% of the volume was for 99% pure glycerol addition. Once the 
glycerol was measured via a beaker and graduated cylinder and added to the container, 
then the remaining volume was filled using deionized water. 
2.4.2 Gunshot (Cylindrical) Wound Model Fabrication and Data Collection 
The cylindrical wound model starts with 3D printing a cylindrical wound shape 







Figure 5. (a) And (b) IPT file of gunshot wound model and (c) Physical 3D 







 The model will also have small cylindrical inlets on the center of the side of the 
cylinder and the bottom with the dimensions of 0.3 cm diameter x 1 cm height once the 
model is 3D printed then the PDMS is created by mixing the elastomer and curing 
agent. Preheat a laboratory isothermal to approximately 100°C (~212°F). Once the 
PDMS mix is created, pour into a 250 mL beaker and add the 3D model in for setting. 
Cover the beaker with aluminum foil and allow it to set for 45 min to 1 hour. Remove the 
3D model carefully and add silicon tubing to each inlet section. Attach one pressure 
gauge per inlet. The bottom inlet will have a T- connector in which one tube will be from 
the fluid reservoir and the other will go to the pressure gauge. Next place 7 ft. of tubing 
from the inlet to the T-connector, this is then connected to a stop cock. The stop cock is 
connected to another ft. of silicon tube which is then fed into a plastic 2 L square 
container in an insulating foam box. Data collection is the same for all foam 
geometries/hemostats. First heat 22% glycerol mix to ~37°C +/- 2°C. Add the fluids to 
the 2 L container in an insulated box and place on 2 L container on a 1.5 cm incline. 
Place the fluid reservoir and wound model at a height in which the silicon tubing is 
stretched its full length for the fluid to move via gravity. Set up a camera to record the 
run, also have a timer in the frame to help with data collection.  Once the model is set 
up, measure the initial weight of the hemostat of choice. Next, observe the pressure via 
the pressure gauges prior to filling in fluids. Then, fill in the wound avoiding overflow and 
measure temperature then record. Turn on the camera and begin videotaping the trial. 
Add in the hemostat, begin timer, open stopcock and allow full fluid flow for 3 minutes. 
Once the 3 minutes ends, close the stop clock rapidly, and remove the hemostat. 




container (this is known as fluid loss). Repeat for all hemostats (i.e. gauze, X-stat®, 
different foam geometries). Data is then observed from the video by recording hemostat 
insertion and removal times, as well as side and bottom pressures of the wound every 
15 seconds for the 3 minutes. 
2.4.3 Grade V Liver In Vitro Model Fabrication and Data Collection 
The ballistic gel grade V wound model starts with 3D printing a wound shape 







Figure 6. (a) Diagram of how the “Double Star” grade V model 3D model 
was made and (b) Physical Double Star 3D model. 
 Once the model is 3D printed then the ballistic gel is created by preheating a 
laboratory isothermal oven to approximately 120°C (~248°F) and placing gel into a 250 
mL beaker. Cover the beaker with aluminum foil and allow it to melt for 3-4 hours. Once 
the gel is melted, pour the gel into a container sized (6.5 in length x 4 in width x 2 in 
depth) and place the 3D model completely into mold immediately. In order to push the 






model. Allow the model to set for 24 hours. Once the model is set, remove the model 
from the mold. Using wooden skewers, create holes at the marked location creating 4 









Figure 7. The grade V model setup. X’s mark where skewers were placed 
for fluid inlets/grade V cut (blue) and pressure outlets for measuring (orange). 
Once the holes are created, fit silicon tubes safely through the holes so they are 
flush to the inside of the model. Attach one pressure gauge to the side tube where fluid 
is not entering, and one pressure gauge to tube flowing out of the bottom. Next, place 2 
ft. of tubing into each of the remaining holes and attach the two free ends to a T-
connector which is then connected to a peristaltic pump that is pumping the 22% 
glycerol fluid. In order to begin trials, heat 22% glycerol mix to ~31 +/- 2°C in a 2 L 
beaker. Place the fluid reservoir next to the peristaltic pump and insert the free end 




to simulate the flow rate of blood in a small porcine liver. Set up a camera to record the 
run, also have a timer in the frame to help with data collection.  Once the model is set 
up, measure the initial weight of the hemostat of choice. Next, observe the pressure via 
the pressure gauges prior to filling in fluids. Then, fill in the wound avoiding overflow and 
measure temperature then record. Turn on the camera and begin videotaping the trial. 
Add in the hemostat, begin timer, start the peristaltic pump and allow full fluid flow for 3 
minutes. Once the 3 minutes ends, stop the peristaltic pump, and remove the hemostat. 
Measure the final weight of the hemostat, turn off camera, and measure the fluid in the 
container (this is known as hemorrhage/fluid loss). Repeat for all hemostats (i.e. X-stat® 
and different foam geometries). Data is then observed from the video by recording 
hemostat insertion and removal times, as well as side and bottom pressures of the 


















3. Results and Discussion 
 
3.1 Foam Characterization 















Figure 8. Average glass transition temperatures based on the state of the control 
foam 
 
 3.1.2 Pore size 
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Figure 10. Volume recovery of a crimped SMP foam. 
 





















Figure 11. (a) 150% and 100% single cylinder foam, (b) Small Foams for 100% and 







 The control foams that were synthesized matched the hemostat design criteria. 
The average dry Tg was 59.06 ± 2.72 °C (Figure 8) and the average wet Tg was 12.12 ± 
0.92 °C (Figure 8). A dry Tg of >50°C and wet Tg of <37°C was desired. The dry Tg 
criterion was important because it showed the control formulation would be able to be 
crimped and stably stored without premature actuation at extreme battlefield 
temperatures.  The reduced wet Tg is required for actuation upon exposure to water in 
blood at body temperature upon implantation. The gunshot in vitro model trials were run 
at ~37°C and the grade V in vitro model trials were run at ~31°C. and it was desired that 
the foams actuate as soon as possible to help control hemorrhaging of the glycerol 
solution. The SEM images show an average pore size of 1177 ± 300 µm, which was 
within the criterion of pores of ~1000 µm (Figure 9) to enable foam crimping. In the 
volume recovery study (Figure 10), the average expansion percentage after 5 minutes 
in 37°C water was 124 ± 49 %. The rapid actuation enables filling of the wounds.  
After ensuring that foams met all design criterion, the different foam geometries were 
constructed in order to test the different forms of hemostats. Figure 11 shows that the 
foams could be fabricated in different geometries and demonstrates the versatility of this 
material. The 150% cylinder diameters were ~4.5 cm and the 100% diameters were 
~3.0 cm. For the small cylinder fill, a variety of small foams were made and separated 
out in order to conduct the trials. The 150% fill required 21 cylinders and the 100% fill 
required 14 cylinders. Lastly, syringes were filled with finely grated foams and had the 
density of ~0.83 g/mL. The control foams maintained their integrity during fabrication, 























































































































































































































































The gauze fill hemostat data in the cylindrical gunshot wound, Figure 12, 
showed that the average bottom pressure was much higher than the average side wall 
pressure. The average bottom pressure was 149 ± 10 mmHg and the side pressure 
were 14 ± 2 mmHg. This was to be expected due to the blood flow coming into the 
model from the bottom. The 22% glycerol and water mixture had to push through the 
bottom of the gauze in order to leave the wound. With the gauze being tightly packed 
into the model, it induced more pressure. The sides maintained lower pressure because 
no fluids were entering from that location, it was only the fluid buildup within the gauze 
that would affect that pressure as it was what was pushing against the walls. Gauze 
was exceptional for controlling the fluid loss as it had an average hemorrhage of 235 ± 
49 mL (Figure 13).  
The 100% and 150% SMP single cylinder fill followed the same trend in having 
higher bottom pressure in comparison to side pressure. The difference between the 
gauze and the SMP hemostat was that the foam hemostat needed time to expand and 
the pressures on both the bottom and the side were much lower. While the foam was 
expanding, it was putting little to no pressure on the side walls and it was allowing a lot 
more fluid to be lost because there was free space for the glycerol mixture to move. The 
average pressure for the bottom of the 100% single cylinder fill was 77 ± 16 mmHg and 
the average pressure for the side was 22 ± 12 mmHg (Figure 12). The average 
pressure for the bottom of the 150% single cylinder fill was 109 ± 12 mmHg and the 
average side pressure was 2.1 ± 0.2 mmHg (Figure 12). The 100% and 150% single 
cylinders had a difference in hemorrhage volume. The averages were 801 ± 103 mL 




bottom of the model between the two fills because the 150% fill has a larger 
circumference to actuate and combat the pressure of the glycerol mixture. The side 
pressures were very different because of how the water actuates with the hemostats. 
Since the 100% single cylinder is smaller and has less crimped material, it is easier for 
the water to enter and expand the foam faster. In comparison, it took a lot longer for the 
150% single fill cylinder to fill reducing wall contact for a large amount of time in the 
trials. Since it took longer for the larger foam to actuate, it had an increased average 
fluid loss, indicating that the 100% fill hemostat may be preferred. In order to improve 
these trials, increasing the temperature to ~37 °C would help cause faster actuation of 
both and potentially give the 150% single cylinder the opportunity to expand more and 
perform more hemorrhage control. 
The 100% small cylinder fill and 150% small cylinder fill followed the same 
bottom and side average pressure, but they had an even bigger gap with the amount of 
fluid loss. Using the smaller foams allowed for an opportunity to better pack the wound 
but it also took a lot more time in comparison to both the gauze and single cylinder fills. 
The average bottom pressure for the 100% small cylinder fill was 77 ± 16 mmHg, and 
the average side pressure was 22 ± 12 mmHg (Figure 12). The average bottom 
pressure for the 150% small cylinder fill was 90 ± 8 mmHg, and the average side 
pressure was 2.2 ± 0.2 mmHg (Figure 12), The pressures followed the same pattern of 
the single cylinder fill where the 150% size placed more pressure on the bottom, but not 
the side. The reasoning for that is similar; there is more packing, but it is harder for the 
water to reach all pieces of foam to enable actuation. Due to the 100% small cylinder fill 




100% small cylinder fill lost a lot of fluid. The average fluid loss for the two geometries 
were 1005 ± 44 mL and 805 ± 108 mL, respectively (Figure 13). The 100% small 
cylinder fill lost the most fluid in comparison to all other hemostats tested, which is 
attributed to reduce wound packing. 
The shredded foams were the most remarkable of all the hemostats. Their 
performance was what was expected of the other hemostats. The shredded foams 
placed a lot of pressure on the bottom of the wound, which is wanted to stop the 
bleeding, and very minimal pressure on the sides. The average bottom pressure for the 
shredded foams was 158 ± 3 mmHg and the average side pressure was 2 ± 1 mmHg 
(Figure 12). With the foam being free to move and very small, enabling almost 
immediate expansion, it reduced the fluid loss. The average fluid loss was 239 ± 53 mL 
(Figure 13), which was the smallest amount loss throughout the entire gunshot wound 
study. 
Using the smaller foams allowed for an opportunity to better pack the wound but 
it also took a lot more time in comparison to both the gauze, single cylinder fills and 
shredded foam. It took approximately 25 seconds to insert the gauze, about 1 second to 
put in the both diameters of compressed single cylinders, about 3 seconds to push in 
shredded foam, and about 30-45 seconds to properly pack the number of cylinders 
required for the trial (Figure 14). For removal time, it took approximately 5 seconds for 
gauze, 2 seconds for the compressed cylinders, 30-35 seconds for small cylinders and 
20 seconds for the shredded foam (Figure 14). This study indicates that it would be 
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 The grade V liver injury in vitro model was designed to be more relevant for the 
intended animal model in pigs. The ballistic gel material is more flexible in comparison 
to the rigid PDMS gunshot wound model, which played a role in the massive decrease 
in the average pressures overall. Based on the gunshot wound model data, the smaller 
cylinders were combined with shredded foam to enable efficient packing of the larger 
wound volume. The grade V model required more intricate packing in respect to the 
gunshot wound model. Thus, the small cylinders were used to fill the bulk of the volume, 
and the shredded foam was used to assist with the reduction of hemorrhage. Before 
beginning the hemostat trials, a series of gauze trials were conducted, and the average 
bottom pressure was 1.5 ± 0.2 mmHg. The side pressure, as expected, was lower and it 
was 1.0 ± 0.1 mmHg (Figure 15). Gauze did an exceptional job of filling the wound and 
preventing massive fluid loss. The average fluid loss for the gauze trials was 982 ± 52 
mL (Figure 16). From the gauze trials, it was hypothesized that the grade V liver injury 
model would follow the same pattern of always having a higher bottom pressure, but 
that was not the case. 
 The hybrid of 100% small cylinder fill and a tube of shredded foams showed the 
opposite trend; the average bottom pressure was 0.8 ± 0.2 mmHg, and the average 
side pressure was 2.1 ± 0.8 mmHg (Figure 15). The model was ideally packed, and the 
hemorrhage loss was around the same as the gauze. It was expected that it would be 
the same because they packed the wound approximately the same way. The average 
fluid loss for the 100% small cylinder and shredded foam trials was 973 ± 16 mL 




 The 150% small cylinder fill and a tube of shredded foams had comparable 
pressures to the 100% hybrid. The average bottom pressure was 1.5 ± 0.8 mmHg and 
the average side pressure was 1.6 ± 0.3 mmHg (Figure 15). For the same pressures 
approximately being applied, the 150% hybrid lost approximately 100 more mL of the 
glycerol mix in comparison to both the gauze and the 100% hybrid. The average 
hemorrhage for these trials was 1076 ± 81 mL (Figure 16).  
 X-Stat® in comparison to all hemostats, performed opposite of expected. The 
bottom and side pressures were not extremely different although they were lower, but 
the hemorrhage loss as well as the actual performance of X-Stat® explains why it 
produced the results that it did. X-Stat® produced an average bottom pressure of 0.6 ± 
0.1 mmHg and an average side pressure of 0.7 ± 0.4 mmHg (Figure 15). The plausible 
reason that the pressures were as low is due to the way that X-Stat® packed the 
wound. The small pieces would go into the wound and expand greatly in comparison to 
their original length in order to soak in the fluid. As the pieces rapidly expanded, they 
pushed other pieces out of the wound and left a lot of gaps which allowed massive fluid 
loss. This hemostat had the greatest average fluid loss of all trials, 1096 ± 224 mL 
(Figure 16). This data indicates that X-Stat® is better for wounds that are deeper. In the 
grade V liver injury in vitro model, horizontal packing was more important than the 
vertical packing required in the gunshot wound model. 
Like the gunshot wound model, using the smaller foams allowed for an 
opportunity to better pack the wound with the assistance of the shredded foam. It took 
approximately 5 seconds to insert the gauze, about 1 second to put in the both 




and about 30-45 seconds to properly pack the number of cylinders required for the trial 
(Figure 17). For removal time, it took approximately 1 seconds for gauze, 2 seconds for 
the compressed cylinders, 30-35 seconds for small cylinders and 20 seconds for the 
shredded foam (Figure 17). This study indicates that it would be better to use the 100% 




























 The series of tests conducted here with a gunshot wound model and a grade V 
liver injury model can enable reduction in future animal studies. In vitro models can be 
tuned to different wound types, and desired measurements can be designed into the 
model. In our case, we were heavily focused on the pressure that the hemostats place 
on the walls and the fluid that is lost after hemostat application. Understanding pressure 
helps us gauge if there would be any damage to the surrounding tissues after 
application. Understanding fluid loss helps us tune the hemostats to better control 
hemorrhaging before wasting the life of an animal. 
 Full size single cylinders shall not be removed from the study when gunshot 
wounds are tested because they are easier to use for both application and removal. The 
cylinders showed that they can mold to the shape of the wound while also covering a lot 
of surface area. From the data obtained here, it is evident that over packing a wound 
does not promise an improvement in hemorrhage control. For future clinical trials, it 
would be advised to use the hybrid hemostats of small cylinders and shredded foam 
that fit the wound more efficiently to avoid hemostat migration. Another observation of 
wound packing is to ensure that the highest pressure of the hemostat is applied to the 
wall where the fluid is coming into. With that control, fluid will hypothetically have a 
greater challenge of escaping the wound and causing massive hemorrhaging. 
 Overall, the construction of in vitro models is very important to the effective 
advancement of medical devices. Each hemostat formulation provided new information 
that will be able to be used to optimize future in vivo pre-clinical trials. The established 
models can be used in future studies to assess alternate geometries and foam 
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